News
For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...
Background The burden of cardiovascular events in Africa is projected to rise significantly in the coming decade, placing ...
4d
Onlymyhealth on MSNMyocardial Infarction vs Heart Attack: Cardiologist Reveals the Key Differences and CausesWhen discussing heart health, the words 'myocardial infarction' and 'heart attack' are used interchangeably as if they are ...
4d
Onlymyhealth on MSNWhat Is the Main Cause of Myocardial Infarction? Doctor ExplainsWhat is the main cause of myocardial infarction A cardiologist explains how atherosclerosis and blood clots trigger heart ...
10hon MSNOpinion
If you haven’t already been killed by the great net neutrality repeal of 2017 or the Title X gag rule of 2019, you’re in luck ...
Mount Nittany Health Emergency Medical Services has been honored with the American Heart Association’s 2025 Mission: Lifeline ...
BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...
Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...
Researchers from The University of Western Australia, working with medtech industry partners Artrya, have developed a new, ...
July 8 (UPI) -- Older women carrying excess weight have a higher risk of a life-threatening double-whammy, a new study says.
Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.
For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results